Funding Opportunities

Frontiers Pilot Program

Frontiers Pilot Program

The Lauren S. Aaronson Frontiers Clinical and Translational Research Pilot Program provides grant funding and other support to grow interdisciplinary, investigator-initiated clinical and translational research across a broad range of scientific disciplines. The Frontiers Pilot Award Program is supported by and aligned with the NCATS Clinical and Translational Science Award (CTSA) Program, which focuses on advancing clinical and translational science (CTS).

Pilot Award RFA

Every year, three one-year pilot projects receive up to $50,000 each in grant support awards.

Inter-Institutional Pilot Project Awards

The Inter-Institutional Pilot Project Awards promote collaboration across the Clinical and Translational Science Award (CTSA) consortium by funding innovative, translational research projects that involve three or more of the six CTSA institutions that make up the CORES Research Collaborative: University of New Mexico Health Sciences Center; University of Kansas Medical Center; University of Kentucky; University of Arkansas for Medical Sciences; University of Iowa; and the University of Utah Health.

In accordance with the National Institutes of Health (NIH) strategic plan and its commitment to increasing representation in research, funding priority for this RFA will be given to research that addresses issues of disparities either because of rurality or underrepresented and disadvantaged groups.

Rurality includes individuals living in rural or frontier communities.

Underrepresented and disadvantaged groups include:

• Ethnic groups that have been shown to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders.
• Individuals with disabilities.
• Individuals from disadvantaged backgrounds.

For more information and expanded definitions, please see the NIH's statement on Underrepresented Populations in the U.S. Biomedical, Clinical Behavioral and Social Science Enterprise.

Involvement of these groups is not a requirement for funding, but projects which address health concerns that disproportionately affect one or more of these groups, or projects that seek to apply or test general treatments to one of more of these groups are preferred.

External Funding Opportunities

At times, there are supplemental and external funding opportunities through NIH and NCATS. Please check for current opportunities here.

Request for Proposals: Pediatric Disease Research

Patton Trust Research Grants

Register and Submit Letter of Intent

Top Takeaways

• Multidisciplinary collaborative research is encouraged
• All full-time researchers at BioNexus KC stakeholder institutions are eligible to submit proposals
• Awards are limited to $50,000 for one year and intended to attract future external funding
• NEW All applicants must register using our online portal

Application Deadlines

• Letter of Intent is due by 5:00 PM on May 25, 2023
• Full application must be received by 5:00 PM on June 28, 2023
• Funding date for successful proposals – September 12, 2023

Resources

• Patton Trust Research Grants RFP
• Online grants portal instructions

If you need additional support, please reach out to Daniel Kennedy

Institute for Advancing Medical Innovation Trailblazer Awards

Frontiers Institute for Advancing Medical Innovation (IAMI) Trailblazer Awards support four targeted areas of clinical and translational research: Experimental Therapeutic trials, Drug and Medical Device Development, Biomarker Discovery and Validation, and Entrepreneurship activities consistent with IAMI's mission.

Applicants may request up to $25,000; lesser amounts are acceptable and encouraged especially if the Frontiers IAMI Trailblazer Award can be used to match or leverage additional resources.

View the full RFA

A goal of Frontiers' funding agency, the National Center for Advancing Translational Sciences, is "to get more treatments to more patients more quickly". The Frontiers IAMI Trailblazer Award addresses this goal by providing funds to help investigators carry out early-stage, feasibility studies to identify drug, diagnostic, and medical device product development opportunities. Data generated from successful studies will be disseminated in impactful publications and support successful extramural funding applications.

Biostatistics, Epidemiology and Research Design Award

The Biostatistics, Epidemiology, and Research Design (BERD) Trailblazer Award provides grant funding to support statistical, epidemiological, and data science investigations toward novel methods development that will improve clinical and translational research (CTR) inferences. BERD Trailblazer Awards support up to $20,000 in research project direct costs for methods development for CTR.  This program is open to faculty investigators across all Frontiers partner institutions.

Full 2023 RFA

Biosketch form

Budget form and justification

Research Plan